A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

Patients with extensive-stage SCLC often respond to induction therapy, but the disease tends to progress rapidly after cytotoxic therapy ends, said Jared Weiss, MD, of the University of North Carolina ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Still, the therapies’ modest benefit as a maintenance therapy points to how better treatments are needed for small cell lung ...

SUPER sensitive cancer blood tests will be rolled out to NHS patients in a world first. People diagnosed with breast or lung ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Open lung resection was linked to higher margin positivity rates than robotic surgery or VATS, with wedge resection and ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...